Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE) http://orcid.org/0000-0002-2502-1372Daniel J Wallace1, Florence Figueras2, William A Wegener3, David M Goldenberg3 1 Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA 2 Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA 3 Immunomedics Inc, Morris Plains, New Jersey, USA...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile